MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Medicenna Therapeutics Corp.
Financials through fiscal 2023, year ended Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)
Close on Oct 19, 2026
Medicenna Therapeutics statistics
Financials through Mar 31, 2023, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Income (trailing twelve months)
| Measure | Medicenna Therapeutics | Industry median |
|---|---|---|
| Pretax Income | -C$10.05M | -C$10.05M |
Balance sheet
| Measure | Medicenna Therapeutics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | C$33.60M | C$18.85M |
| Net Cash (Debt) | C$33.60M | C$16.52M |
| Net Cash Per Share | 0.48 CAD | 0.25 CAD |
| Working Capital | C$32.59M | C$15.82M |
Financial position
| Measure | Medicenna Therapeutics | Industry median |
|---|---|---|
| Current Ratio | 9.57 | 3.87 |
| Quick Ratio | 8.84 | 2.47 |
Efficiency
| Measure | Medicenna Therapeutics | Industry median |
|---|---|---|
| Employee Count | 16 | 22 |
Shares
| Measure | Medicenna Therapeutics | Industry median |
|---|---|---|
| Shares Outstanding | 69,637,500 | 74,643,400 |
| Shares Change (YoY) | 19.2% | 17.9% |
| Float | 69,637,500 | 74,292,200 |
| Shares Held by Insiders | 0.00% | 0.00% |
Taxes
| Measure | Medicenna Therapeutics | Industry median |
|---|---|---|
| Income Tax | C$0 | C$0 |
Calculated by StockData from Medicenna Therapeutics's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.